Search Results for "Fulminant Ms"
Original Source: Fulminant multiple sclerosis (MS).
Fulminant multiple sclerosis (MS) is the most malignant form of MS which usually leads to death in few weeks. Although it can be accompanied by optic neuritis (ON), but long interval between ON and the grave onset has not been reported. Fulminant MS usually occurs as the first onset and previous ON is not common. We report a rare case of 30-year-old woman with a history of ON 1 year ago. The rapid deterioration to vegetative state followed by a seizure and previous ON differentiated this case from previous...
Matching Channels
Matching News
Fulminant Hepatic Failure in Association With Quetiapine
This case highlights the importance of considering drug-induced hepatotoxicity in cases of fulminant hepatic failure. Journal of Medical Case Reports
Local Gastroenterologists First in South Florida to Offer Fecal Transplant
CORAL SPRINGS, Fla., Aug. 7, 2012 /PRNewswire/ -- Digestive CARE™, a medical group of 52 gastroenterologists in Broward and Palm Beach County, today announced that they are the first gastro...
BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that significantly more moderate-to-severe and s...
[Comment] The burden of serogroup B meningococcal disease
Neisseria meningitidis is the leading cause of meningitis and severe sepsis in children and young adults worldwide. The central pathophysiological event in meningococcal disease is bacteraemia, and pa...
Vital Therapies Inc. (San Diego, Calif.) raised $16 million in the first close of a planned $76 million financing from undisclosed existing investors. In 4Q12, Vital plans to enroll the first patient...
[Vital Therapies] raises $16mm out of potential $76mm Series E financing
[Vital Therapies Inc.] (developing a cell therapeutic/device that processes liver toxins and synthesizes proteins critical for liver function) raised $16mm in a Series E financing led by returning sha...
SAN DIEGO, CA -- (Marketwire) -- 09/27/12 -- Vital Therapies, Inc., a development stage biotechnology company focused on human allogeneic cellular therapy for life-threatening acute liver failure, to...
SAN DIEGO, CA -- (Marketwire) -- 03/04/13 -- La Jolla Pharmaceutical Company (www.ljpc.com) (OTCQB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting galectin pr...
Matching PubMed Articles
Low CTLA-4 expression in CD4+ helper T-cells in patients with fulminant type 1 diabetes.
Fulminant type 1 diabetes is a novel subtype of type 1 diabetes characterized by a remarkably abrupt onset of insulin-deficient hyperglycemia. An accelerated immune reaction has been suggested as the...
ABSTRACT: Fulminant myocarditis frequently results in severe hemodynamic deterioration. High-dose vasopressors or sometimes mechanical circulatory support are required. We report on two cases of fulmi...
Acute fulminant myocarditis is a life-threatening disease in children. A limited number of reports suggest that mechanical circulatory support (MCS) may be used to successfully bridge children with a...
AIM: Cerebral hemodynamic derangement is well known in patients with fulminant hepatic failure. The advent of transcranial Doppler sonography (TCD) enabled noninvasive observation of cerebral hemodyna...
Severe Guillain-Barré syndrome following head trauma.
Fulminant forms of Guillain-Barré syndrome (GBS) present as acute onset tetraparesis and areflexia with absent brainstem reflexes, simulating brain death. Head trauma as an antecedent to fulminant GB...
